Celltrion, Inc. et al. vs. Genentech, Inc.
Explore the PTAB proceeding IPR2018-01019 filed by Celltrion, Inc. et al. on 2018-05-04. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.
Proceeding Overview
Proceeding Number
IPR2018-01019
Filing Date
2018-05-04
Accorded Filing Date
2018-05-04
Institution Decision Date
2018-10-30
Last Modified Date
2024-01-11
Proceeding Type
IPR
Termination Date
2018-10-30
Trial Status
Terminated
Parties & Counsel
Petitioner
Celltrion, Inc. et al.
Represented By
Holland, Elizabethet alPatent Owner / Respondent
Genentech, Inc.
Represented By
Baughman, J. Stevenet alPatent Information
Tribunal & APJ Panel Intelligence
Tribunal
Patent Trial and Appeal Board (USPTO)
Technology Center
TC 1600 - Biotechnology & Organic Chemistry
Decisions Rendered
0 Total
Proceeding Status
Terminated
Administrative Patent Judges (APJ Panel)
Address and Attorney/Agent Information
Power of Attorney & Correspondence
Attorney / Agent Information
| Reg # | Name | Phone |
|---|---|---|
| 35910 | Sean Johnston | +1 650-225-3562 |
| 39209 | Robert Hall | +1 650-225-8203 |
| 40378 | Wendy Lee | +1 650-225-1994 |
| 46585 | Brian Buckwalter | +1 650-225-8018 |
| 46631 | Cara Coburn | +1 650-225-1000 |
| 47668 | Susan Hubl | +1 650-763-7326 |
| 48314 | Grant Kalinowski | +1 650-467-2607 |
| 48492 | Gregory Zinkl | +1 650-922-2382 |
Global Patent Family Cross-Litigation Radar
CasLoc 360ยฐ Radar 4 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| ๐บ๐ธ United States | US 7,976,838 B2 Asserted | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 2011030013 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 46,148,103 P | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 2004020265 | US Continuation / Sibling | View Official Patent → |
Boehringer Ingelheim Pharmaceuticals, Inc. v. Genentech, Inc.